These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 32269054)

  • 1. Early Hepatic Lesions Display Immature Tertiary Lymphoid Structures and Show Elevated Expression of Immune Inhibitory and Immunosuppressive Molecules.
    Meylan M; Petitprez F; Lacroix L; Di Tommaso L; Roncalli M; Bougoüin A; Laurent A; Amaddeo G; Sommacale D; Regnault H; Derman J; Charpy C; Lafdil F; Pawlotsky JM; Sautès-Fridman C; Fridman WH; Calderaro J
    Clin Cancer Res; 2020 Aug; 26(16):4381-4389. PubMed ID: 32269054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma.
    Calderaro J; Petitprez F; Becht E; Laurent A; Hirsch TZ; Rousseau B; Luciani A; Amaddeo G; Derman J; Charpy C; Zucman-Rossi J; Fridman WH; Sautès-Fridman C
    J Hepatol; 2019 Jan; 70(1):58-65. PubMed ID: 30213589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritumoral Tertiary Lymphoid Structures Correlate With Protective Immunity and Improved Prognosis in Patients With Hepatocellular Carcinoma.
    Li H; Liu H; Fu H; Li J; Xu L; Wang G; Wu H
    Front Immunol; 2021; 12():648812. PubMed ID: 34122408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Existence of intratumoral tertiary lymphoid structures is associated with immune cells infiltration and predicts better prognosis in early-stage hepatocellular carcinoma.
    Li H; Wang J; Liu H; Lan T; Xu L; Wang G; Yuan K; Wu H
    Aging (Albany NY); 2020 Feb; 12(4):3451-3472. PubMed ID: 32087064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of tertiary lymphoid structures in hepatocellular carcinoma: a meta-analysis and systematic review.
    Hu L; Li X; Yang C; Zhou B; Du C; Jiang N
    Front Immunol; 2024; 15():1390938. PubMed ID: 38887293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annexin A2 promotion of hepatocellular carcinoma tumorigenesis
    Qiu LW; Liu YF; Cao XQ; Wang Y; Cui XH; Ye X; Huang SW; Xie HJ; Zhang HJ
    World J Gastroenterol; 2020 May; 26(18):2126-2137. PubMed ID: 32476780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific patterns of PIWI-interacting small noncoding RNA expression in dysplastic liver nodules and hepatocellular carcinoma.
    Rizzo F; Rinaldi A; Marchese G; Coviello E; Sellitto A; Cordella A; Giurato G; Nassa G; Ravo M; Tarallo R; Milanesi L; Destro A; Torzilli G; Roncalli M; Di Tommaso L; Weisz A
    Oncotarget; 2016 Aug; 7(34):54650-54661. PubMed ID: 27429044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability of a single-region sample to evaluate tumor immune microenvironment in hepatocellular carcinoma.
    Shen YC; Hsu CL; Jeng YM; Ho MC; Ho CM; Yeh CP; Yeh CY; Hsu MC; Hu RH; Cheng AL
    J Hepatol; 2020 Mar; 72(3):489-497. PubMed ID: 31634533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral cancer-associated tertiary lymphoid structures: gene expression profile and prognostic value.
    Li K; Guo Q; Zhang X; Dong X; Liu W; Zhang A; Li Y; Yan J; Jia G; Zheng Z; Tang W; Pan L; An M; Zhang B; Liu S; Fu B
    Clin Exp Immunol; 2020 Feb; 199(2):172-181. PubMed ID: 31652350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Absence of Intra-Tumoral Tertiary Lymphoid Structures is Associated with a Worse Prognosis and mTOR Signaling Activation in Hepatocellular Carcinoma with Liver Transplantation: A Multicenter Retrospective Study.
    Li J; Zhang L; Xing H; Geng Y; Lv S; Luo X; He W; Fu Z; Li G; Hu B; Jiang S; Yang Z; Zhu N; Zhang Q; Zhao J; Tao Y; Shen C; Li R; Tang F; Zheng S; Bao Y; He Q; Geng D; Wang Z
    Adv Sci (Weinh); 2024 Jun; 11(21):e2309348. PubMed ID: 38498682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological potential of tertiary lymphoid structures surrounding the primary tumor in gastric cancer.
    Yamakoshi Y; Tanaka H; Sakimura C; Deguchi S; Mori T; Tamura T; Toyokawa T; Muguruma K; Hirakawa K; Ohira M
    Int J Oncol; 2020 Jul; 57(1):171-182. PubMed ID: 32319601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma.
    Ramzan M; Sturm N; Decaens T; Bioulac-Sage P; Bancel B; Merle P; Tran Van Nhieu J; Slama R; Letoublon C; Zarski JP; Jouvin-Marche E; Marche PN; Leroy V
    Liver Int; 2016 Mar; 36(3):434-44. PubMed ID: 26215124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Group-2 Innate Lymphoid Cells Promote HCC Progression Through CXCL2-Neutrophil-Induced Immunosuppression.
    Xu X; Ye L; Zhang Q; Shen H; Li S; Zhang X; Ye M; Liang T
    Hepatology; 2021 Nov; 74(5):2526-2543. PubMed ID: 33829508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tertiary lymphoid structures: Associated multiple immune cells and analysis their formation in hepatocellular carcinoma.
    Nie Y; Fan H; Li J; Lei X; Zhang T; Wang Y; Mao Z; Tao K; Song W
    FASEB J; 2022 Nov; 36(11):e22586. PubMed ID: 36190431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
    Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
    BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantifying Tertiary Lymphoid Structure-Associated Genes in Formalin-Fixed Paraffin-Embedded Breast Cancer Tissues.
    Gu-Trantien C; Garaud S; Migliori E; Solinas C; Lodewyckx JN; Willard-Gallo K
    Methods Mol Biol; 2018; 1845():139-157. PubMed ID: 30141012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tertiary lymphoid structures in the era of cancer immunotherapy.
    Sautès-Fridman C; Petitprez F; Calderaro J; Fridman WH
    Nat Rev Cancer; 2019 Jun; 19(6):307-325. PubMed ID: 31092904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
    Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
    World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune repertoire: A potential biomarker and therapeutic for hepatocellular carcinoma.
    Han Y; Li H; Guan Y; Huang J
    Cancer Lett; 2016 Sep; 379(2):206-12. PubMed ID: 26188280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive receptor LILRB1 acts as a potential regulator in hepatocellular carcinoma by integrating with SHP1.
    Cheng J; Luan J; Chen P; Kuang X; Jiang P; Zhang R; Chen S; Cheng F; Gou X
    Cancer Biomark; 2020; 28(3):309-319. PubMed ID: 32390601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.